These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29467644)

  • 1. Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.
    Baig MH; Ahmad K; Rabbani G; Choi I
    Front Aging Neurosci; 2018; 10():21. PubMed ID: 29467644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of BACE1 in Alzheimer's synaptic function.
    Das B; Yan R
    Transl Neurodegener; 2017; 6():23. PubMed ID: 28855981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    Savage MJ; Holder DJ; Wu G; Kaplow J; Siuciak JA; Potter WZ;
    J Alzheimers Dis; 2015; 46(2):431-40. PubMed ID: 25790831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease.
    Naushad M; Durairajan SSK; Bera AK; Senapati S; Li M
    Planta Med; 2019 Nov; 85(17):1316-1325. PubMed ID: 31618777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-secretase (BACE) as a drug target for Alzheimer's disease.
    Vassar R
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1589-602. PubMed ID: 12453676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
    Gerszon J; Rodacka A
    Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs.
    Yan R
    Transl Neurodegener; 2016; 5():13. PubMed ID: 27418961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment.
    Coimbra JRM; Marques DFF; Baptista SJ; Pereira CMF; Moreira PI; Dinis TCP; Santos AE; Salvador JAR
    Front Chem; 2018; 6():178. PubMed ID: 29881722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease.
    Evin G; Barakat A
    Degener Neurol Neuromuscul Dis; 2014; 4():1-19. PubMed ID: 32669897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
    Volloch V; Olsen B; Rits S
    Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.
    Moussa CE
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1131-1136. PubMed ID: 28817311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACE inhibitors in clinical development for the treatment of Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Sardone R; Piccininni C; Dibello V; Stallone R; Giannelli G; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G; Imbimbo BP
    Expert Rev Neurother; 2018 Nov; 18(11):847-857. PubMed ID: 30277096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of multi-target compounds as AChE, BACE1, and amyloid-β(1-42) oligomerization inhibitors: in silico and in vitro studies.
    Hernández-Rodríguez M; Correa-Basurto J; Martínez-Ramos F; Padilla-Martínez II; Benítez-Cardoza CG; Mera-Jiménez E; Rosales-Hernández MC
    J Alzheimers Dis; 2014; 41(4):1073-85. PubMed ID: 24762947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
    Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
    Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
    Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
    FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.